BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that its shares of common stock have been approved for uplisting to the NASDAQ Capital Market, and will commence trading on the NASDAQ Capital Market when trading begins on September 30, 2014. "We are so happy to bring BrainStorm's common stock to NASDAQ.
http://ift.tt/1v5YtGg
http://ift.tt/1v5YtGg
No comments:
Post a Comment